Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity
Lei Tian(City Of Hope National Medical Center), Jianhua Yu(City Of Hope National Medical Center)
Cited by 73
Related Papers
YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells
|Nature Immunology|2023|217
An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma
|Cancer Research|2021|210
Transcription Factor Foxo1 Is a Negative Regulator of Natural Killer Cell Maturation and Function
|Immunity|2015|184